Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kelsh

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Radiation Research|July 20, 2007
Factors that influence the radiofrequency power output of GSM mobile phonesLinda S Erdreich, Maria D Van Kerkhove, Carolyn G Scrafford, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid LeukemiaFarhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Advances in Therapy|April 18, 2021
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical PracticeSara J Snell Taylor, Carrie M Nielson, Alexander Breskin, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Radiation Research|July 20, 2007
Factors that influence the radiofrequency power output of GSM mobile phonesLinda S Erdreich, Maria D Van Kerkhove, Carolyn G Scrafford, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 15, 2020
Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid LeukemiaFarhad Ravandi, Sherry Pierce, Guillermo Garcia-Manero, et al.
Clinical Pharmacology and Therapeutics|August 20, 2021
Lessons Learned Using Real-World Data to Emulate Randomized Trials: A Case Study of Treatment Effectiveness for Newly Diagnosed Immune ThrombocytopeniaLeah J McGrath, Carrie Nielson, Bradley Saul, et al.
Haematologica|September 3, 2016
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemiaNicola Gökbuget, Hervè Dombret, Jose-Maria Ribera, et al.
Advances in Therapy|April 18, 2021
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical PracticeSara J Snell Taylor, Carrie M Nielson, Alexander Breskin, et al.
Pageof 2